- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/775 - Apolipopeptides
Détention brevets de la classe C07K 14/775
Brevets de cette classe: 553
Historique des publications depuis 10 ans
|
41
|
43
|
29
|
41
|
46
|
42
|
39
|
27
|
33
|
11
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 18943 |
25 |
| CSL Limited | 251 |
16 |
| Cerenis Therapeutics Holding SA | 30 |
13 |
| F. Hoffmann-La Roche AG | 7958 |
10 |
| ABIONYX Pharma SA | 28 |
9 |
| Lawrence Livermore National Security, LLC | 1834 |
8 |
| University of Cincinnati | 797 |
8 |
| Toray Industries, Inc. | 6652 |
7 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
7 |
| Children's Medical Center Corporation | 1780 |
7 |
| Cornell University | 3036 |
7 |
| National Cancer Center | 365 |
7 |
| Centre National de La Recherche Scientifique | 9632 |
6 |
| Duke University | 2872 |
6 |
| Quest Diagnostics Investments Incorporated | 432 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
6 |
| Vect-Horus | 19 |
6 |
| Theripion, Inc. | 12 |
6 |
| The General Hospital Corporation | 4517 |
5 |
| Cleveland HeartLab, Inc. | 19 |
5 |
| Autres propriétaires | 383 |